Longitudinal prognostic value of the most common algorithms for fibrosis in non-alcoholic fatty liver disease. An international study in non-cirrhotic, biopsy-proven patients

Background and aims: As fibrosis is the main determinant of progressive disease in NAFLD patients, and considering the lack of fibrosis biomarkers able to predict liver-related morbidity and mortality, we aimed at validating the long-term prognostic value of the most currently used non-invasive fibrosis scores in a cohort of biopsy-proven NAFLD...